These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35930494)

  • 21. The significance of the choice of radiobiological (NTCP) models in treatment plan objective functions.
    Miller J; Fuller M; Vinod S; Suchowerska N; Holloway L
    Australas Phys Eng Sci Med; 2009 Jun; 32(2):81-7. PubMed ID: 19623858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
    Mavroidis P; Ferreira BC; Lopes Mdo C
    Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.
    Hedin E; Bäck A
    J Appl Clin Med Phys; 2013 Sep; 14(5):127-39. PubMed ID: 24036865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
    Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
    Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsilateral lung normal tissue complication probability parameters for different dose calculation algorithms in radiotherapy of breast cancer.
    Kavousi N; Nedaie HA; Gholami S; Esfahani M; Shafiekhani S; Hassani M
    J Cancer Res Ther; 2020; 16(6):1323-1330. PubMed ID: 33342791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between pneumonitis risk in radiation oncology and lung density measured with X-ray computed tomography.
    Chaikh A; Balosso J
    Quant Imaging Med Surg; 2016 Aug; 6(4):413-417. PubMed ID: 27709077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of NTCP parameter values against a change of dose calculation algorithm.
    Brink C; Berg M; Nielsen M
    Med Phys; 2007 Sep; 34(9):3579-86. PubMed ID: 17926961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
    Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
    Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?
    Chaikh A; Docquière N; Bondiau PY; Balosso J
    Transl Lung Cancer Res; 2016 Dec; 5(6):673-680. PubMed ID: 28149761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
    Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
    Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal tissue complication probabilities: dependence on choice of biological model and dose-volume histogram reduction scheme.
    Moiseenko V; Battista J; Van Dyk J
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):983-93. PubMed ID: 10705021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics.
    Patel G; Mandal A; Bharati A; Choudhary S; Mishra R; Mourya A
    J Cancer Res Ther; 2022; 18(6):1697-1705. PubMed ID: 36412432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
    Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
    Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dose calculation algorithms on the predicted dose distribution and NTCP values for NSCLC patients.
    Nielsen TB; Wieslander E; Fogliata A; Nielsen M; Hansen O; Brink C
    Med Phys; 2011 May; 38(5):2412-8. PubMed ID: 21776775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A theoretical approach to the problem of dose-volume constraint estimation and their impact on the dose-volume histogram selection.
    Schinkel C; Stavrev P; Stavreva N; Fallone BG
    Med Phys; 2006 Sep; 33(9):3444-59. PubMed ID: 17022241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.